Abstract
Gene expression biomarkers are now available for application in the identification of genotoxic hazards. The TGx‐DDI transcriptomic biomarker can accurately distinguish DNA damage‐inducing (DDI) from non‐DDI exposures based on changes in the expression of 64 biomarker genes. The 64 genes were previously derived from whole transcriptome DNA microarray profiles of 28 reference agents (14 DDI and 14 non‐DDI) after 4 h treatments of TK6 human lymphoblastoid cells. To broaden the applicability of TGx‐DDI, we tested the biomarker using quantitative RT‐PCR (qPCR), which is accessible to most molecular biology laboratories. First, we selectively profiled the expression of the 64 biomarker genes using TaqMan qPCR assays in 96‐well arrays after exposing TK6 cells to the 28 reference agents for 4 h. To evaluate the classification capability of the qPCR profiles, we used the reference qPCR signature to classify 24 external validation chemicals using two different methods—a combination of three statistical analyses and an alternative, the Running Fisher test. The qPCR results for the reference set were comparable to the original microarray biomarker; 27 of the 28 reference agents (96%) were accurately classified. Moreover, the two classification approaches supported the conservation of TGx‐DDI classification capability using qPCR; the combination of the two approaches accurately classified 21 of the 24 external validation chemicals, demonstrating 100% sensitivity, 81% specificity, and 91% balanced accuracy. This study demonstrates that qPCR can be used when applying the TGx‐DDI biomarker and will improve the accessibility of TGx‐DDI for genotoxicity screening. Environ. Mol. Mutagen. 60: 122–133, 2019. © 2018 Her Majesty the Queen in Right of Canada Environmental and Molecular Mutagenesis.
Highlights
The application of toxicogenomics (TGx) in chemical toxicity testing has been a continuously developing area of in vitro toxicology since the introduction of TGx nearly two decades ago (Nuwaysir et al, 1999; Li et al, 2007; Uehara et al, 2010)
In the principal component analysis (PCA), 2-deoxyglucose (2-DG), a non-DDI agent, clustered with DDI chemicals, and methotrexate (MTX) and cadmium chloride, two DDI agents clustered with non
The Running Fisher test of the Quantitative real-time PCR (qPCR) profiles of the TGxDDI reference set demonstrated an improvement in accuracy by classifying 27 reference agents correctly (96%)
Summary
The application of toxicogenomics (TGx) in chemical toxicity testing has been a continuously developing area of in vitro toxicology since the introduction of TGx nearly two decades ago (Nuwaysir et al, 1999; Li et al, 2007; Uehara et al, 2010). Various TGx signatures have been produced that show promise for application in genotoxic hazard identification (Amundson et al, 2005; EllingerZiegelbauer et al, 2009; Magkoufopoulou et al, 2012; Li et al, 2015). TGx analyses provide transcriptional response information that cannot be obtained using the current standard in vitro genotoxicity assays (Thybaud et al, 2007; Zeiger et al, 2015). These biomarkers can be used to measure the initiation of DNA damage response genes and pathways to identify chemicals operating through DNA damage-inducing (DDI) or potentially other mechanisms. TGx can complement standard in vitro genotoxicity assays by providing mechanistic context to the observed DNA damage for human-relevant hazard identification
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.